Positive study results for Penthrox in Europe
22 October 2019
Positive study results for Penthrox? demonstrating superiority over Standard of Care for acute trauma pain treatments in patients across Europe
Medical Developments International Limited (ASX: MVP) is delighted to announce that data across 11 abstracts of studies conducted throughout Europe and presented at the EUSEM Congress on October 12th to 14th 2019 have demonstrated multiple positive results of Penthrox?
For further detail please click on the following link – Positive study results of Penthrox in Europe